Diabetes, Obesity and Metabolism, 1462-8902

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Investigating optimal β-cell-preserving treatment in latent autoimmune diabetes in adults: Results from a 21-month randomized trial

    Hals, I. K., Fiskvik Fleiner, H., Reimers, N., Astor, M. C., Karin Filipsson, Ma, Z., Grill, V. & Björklund, A., 2019 maj 30, I : Diabetes, Obesity and Metabolism.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case–control study

    The SUMMIT consortium, Natali, A., Nesti, L., Venturi, E., Shore, A. C., Khan, F., Gooding, K., Gates, P. E., Looker, H. C., Dove, F., Isabel Goncalves, Margaretha Persson & Jan Nilsson, 2019 feb, I : Diabetes, Obesity and Metabolism. 21, 2, s. 412-416

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2018
  5. MicroRNAs in islet hormone secretion

    Jonathan L.S. Esguerra, Mototsugu Nagao, Jones K. Ofori, Anna Wendt & Lena Eliasson, 2018 sep 1, I : Diabetes, Obesity and Metabolism. 20, Suppl 2, s. 11-19

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  6. Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials

    Bo Ahrén, Atkin, S. L., Charpentier, G., Warren, M. L., Wilding, J. P. H., Birch, S., Holst, A. G. & Leiter, L. A., 2018 sep 1, I : Diabetes, Obesity and Metabolism. 20, 9, s. 2210-2219 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Different glucagon effects during DPP-4 inhibition versus SGLT-2 inhibition in metformin-treated type 2 diabetes patients

    Alsalim, W., Margaretha Persson & Bo Ahrén, 2018 jul, I : Diabetes, Obesity and Metabolism. 20, 7, s. 1652-1658

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects

    Alsalim, W., Olga Göransson, Carr, R. D., Bizzotto, R., Tura, A., Pacini, G., Mari, A. & Bo Ahrén, 2018 apr, I : Diabetes, Obesity and Metabolism. 20, 4, s. 1080-1085

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2017
  10. Effects of DPP-4 inhibitor linagliptin and GLP-1 receptor agonist liraglutide on physiological response to hypoglycaemia in Japanese subjects with type 2 diabetes: A randomized, open-label, 2-arm parallel comparative, exploratory trial

    Yabe, D., Eto, T., Shiramoto, M., Irie, S., Murotani, K., Seino, Y., Kuwata, H., Kurose, T., Seino, S., Bo Ahrén & Seino, Y., 2017, I : Diabetes, Obesity and Metabolism. 19, 3, s. 442-447

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes

    Preiss, D., Dawed, A., Welsh, P., Heggie, A., Jones, A. G., Dekker, J., Robert Koivula, Hansen, T. H., Stewart, C., Holman, R. R., Paul W. Franks, Walker, M., Pearson, E. R. & Sattar, N., 2017, I : Diabetes, Obesity and Metabolism. 19, 3, s. 356-363

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2016
  13. Mixed meal diminishes glucose excursion compared to glucose by several adaptive mechanisms in man.

    Alsalim, W., Tura, A., Pacini, G., Omar, B., Bizzotto, R., Mari, A. & Bo Ahrén, 2016, I : Diabetes, Obesity and Metabolism. 18, 1, s. 24-33

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2015
  15. The Islet and Metabolism Keep Time

    Thorens, B., Accili, D., Bo Ahrén, Cerasi, E., Seino, S. & Boitard, C., 2015, I : Diabetes, Obesity and Metabolism. 17, Suppl 1, s. 3-5

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  16. 2014
  17. Pronounced Reduction Of Postprandial Glucagon By Lixisenatide: A Meta-Analysis Of Randomized Clinical Trials.

    Bo Ahrén, Gautier, J-F., Berria, R., Stager, W., Aronson, R. & Bailey, C. J., 2014, I : Diabetes, Obesity and Metabolism. 16, 9, s. 861-868

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. The mind and the belly: a glance at how the nervous system directs metabolism

    Accili, D., Bo Ahrén, Boitard, C., Seino, S., Thorens, B. & Cerasi, E., 2014, I : Diabetes, Obesity and Metabolism. 16, s. 1-3

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  19. 2013
  20. Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

    Monami, M., Bo Ahrén, Dicembrini, I. & Mannucci, E., 2013, I : Diabetes, Obesity and Metabolism. 15, 2, s. 112-120

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Glucose-lowering effect of the DPP-4 inhibitor sitagliptin after glucose and non-glucose macronutrient ingestion in non-diabetic subjects.

    Lena Ohlsson, Alsalim, W., Carr, R. D., Tura, A., Pacini, G., Mari, A. & Bo Ahrén, 2013, I : Diabetes, Obesity and Metabolism. 15, 6, s. 531-537

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

    Nauck, M., Frid, A., Hermansen, K., Thomsen, A. B., During, M., Shah, N., Tankova, T., Mitha, I. & Matthews, D. R., 2013, I : Diabetes, Obesity and Metabolism. 15, 3, s. 204-212

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Shifting the paradigm of islet inflammation-good guy or bad guy?

    Bo Ahrén, Accili, D., Boitard, C., Cerasi, E., Thorens, B. & Seino, S., 2013, I : Diabetes, Obesity and Metabolism. 15, s. 4-9

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  24. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function

    Alba, M., Bo Ahrén, Inzucchi, S. E., Guan, Y., Mallick, M., Xu, L., O'Neill, E. A., Williams-Herman, D. E., Kaufman, K. D. & Goldstein, B. J., 2013, I : Diabetes, Obesity and Metabolism. 15, 12, s. 1101-1110

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. 2012
  26. The hyperstimulated beta-cell: prelude to diabetes?

    Boitard, C., Accili, D., Bo Ahrén, Cerasi, E., Seino, S. & Thorens, B., 2012, I : Diabetes, Obesity and Metabolism. 14, S3, s. iv-viii

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  27. Using albumin to improve the therapeutic properties of diabetes treatments.

    Bo Ahrén & Burke, B., 2012, I : Diabetes, Obesity and Metabolism. 14, s. 121-129

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. 2011
  29. Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)

    Lindblad, U., Lindberg, G., Månsson, N-O., Jonas Ranstam, Tyrberg, M., Jansson, S., Lindwall, K., Svärdh, M., Kindmalm, L. & Melander, A., 2011, I : Diabetes, Obesity and Metabolism. 13, 2, s. 185-188

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  30. Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin.

    Bo Ahrén, Foley, J. E. & Bosi, E., 2011, I : Diabetes, Obesity and Metabolism. 13, 3, s. 193-203

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.

    Ola Lindgren, Carr, R., Holst, J. J., Deacon, C. & Bo Ahrén, 2011, I : Diabetes, Obesity and Metabolism. 13, s. 863-865

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Editorial: Long in the shade, glucagon re-occupies centre court

    Henquin, J. -C., Accili, D., Bo Ahrén, Boitard, C., Seino, S. & Cerasi, E., 2011, I : Diabetes, Obesity and Metabolism. 13, Suppl. 1, s. V-VIII

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  33. Gastric bypass surgery, but not caloric restriction, decreases dipeptidyl peptidase 4 activity in obese patients with type 2 diabetes.

    Alam, M., Van der Schueren, B. J., Bo Ahrén, Wang, G. C., Swerdlow, N. J., Arias, S., Bose, M., Gorroochurn, P., Teixeira, J., McGinty, J. & Laferrère, B., 2011, I : Diabetes, Obesity and Metabolism. 13, 4, s. 378-381

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Mechanisms of Action of the DPP-4 Inhibitor Vildagliptin in Man.

    Bo Ahrén, Schweizer, A., Dejager, S., Villhauer, E. B., Dunning, B. E. & Foley, J. E., 2011, I : Diabetes, Obesity and Metabolism. 13, 9, s. 775-783

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  35. The future of incretin-based therapy: novel avenues-novel targets.

    Bo Ahrén, 2011, I : Diabetes, Obesity and Metabolism. 13 Suppl 1, s. 158-166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. 2010
  37. A low glycaemic diet improves oral glucose tolerance but has no effect on β-cell function in C57BL/6J mice.

    Ulrika Axling, Rosén, L., Nils Wierup, Östman, E., Björck, I. & Cecilia Holm, 2010, I : Diabetes, Obesity and Metabolism. 12, 11, s. 976-982

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

    Matthews, D. R., Dejager, S., Bo Ahrén, Fonseca, V., Ferrannini, E., Couturier, A., Foley, J. E. & Zinman, B., 2010, I : Diabetes, Obesity and Metabolism. 12, 9, s. 780-789

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. What ails the beta-cell?

    Accili, D., Bo Ahrén, Boitard, C., Cerasi, E., Henquin, J. -C. & Seino, S., 2010, I : Diabetes, Obesity and Metabolism. 12, s. 1-3

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  40. 2009
  41. beta-Cell research - A decade of rapid growth

    Bo Ahrén, Accili, D., Boitard, C., Efendic, S., Henquin, J-C., Seino, S., Steiner, D. F. & Cerasi, E., 2009, I : Diabetes, Obesity and Metabolism. 11, s. IV-IX

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery

    Guldstrand, M., Bo Ahrén, Naslund, E., Holst, J. J. & Adamson, U., 2009, I : Diabetes, Obesity and Metabolism. 11, 11, s. 1027-1033

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes

    Lund, S. S., Tarnow, L., Astrup, A. S., Hovind, P., Jacobsen, P. K., Alibegovic, A. C., Parving, I., Pietraszek, L., Frandsen, M., Rossing, P., Parving, H. -H. & Allan Vaag, 2009, I : Diabetes, Obesity and Metabolism. 11, 10, s. 966-977

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

    Ferrannini, E., Fonseca, V., Zinman, B., Matthews, D., Bo Ahrén, Byiers, S., Shao, Q. & Dejager, S., 2009, I : Diabetes, Obesity and Metabolism. 11, 2, s. 157-166

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. Functional SOCS1 polymorphisms are associated with variation in obesity in whites

    Gylvin, T., Ek, J., Nolsoe, R., Albrechtsen, A., Andersen, G., Bergholdt, R., Brorsson, C., Bang-Berthelsen, C. H., Hansen, T., Karlsen, A. E., Billestrup, N., Borch-Johnsen, K., Jorgensen, T., Pedersen, O., Mandrup-Poulsen, T., Nerup, J. & Pociot, F., 2009, I : Diabetes, Obesity and Metabolism. 11, 3, s. 196-203

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Genetic basis of beta-cell dysfunction in man.

    Leif Groop & Valeriya Lyssenko, 2009, I : Diabetes, Obesity and Metabolism. 11 Suppl 4, s. 149-158

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. Identification of T1D susceptibility genes within the MHC region by combining protein interaction networks and SNP genotyping data

    Brorsson, C., Hansen, N. T., Lage, K., Bergholdt, R., Brunak, S. & Pociot, F., 2009, I : Diabetes, Obesity and Metabolism. 11, S1, s. 60-66

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Inhibitory effect of kisspeptins on insulin secretion from isolated mouse islets.

    Vikman, J. & Bo Ahrén, 2009, I : Diabetes, Obesity and Metabolism. 11 Suppl 4, s. 197-201

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. 2008
  50. Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up

    Alvarsson, M., Sundkvist, G., Lager, I., Kerstin Berntorp, Fernqvist-Forbes, E., Steen, L., Örn, T., Holberg, M. A., Kirksaether, N. & Grill, V., 2008, I : Diabetes, Obesity and Metabolism. 10, 5, s. 421-429

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. Efficacy and tolerability of vildagliptin in drug-naive patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Jauffret, S. & Foley, J. E., 2008, I : Diabetes, Obesity and Metabolism. 10, 8, s. 675-682

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Evidence that vildagliptin attenuates deterioration of glycaemic control during 2-year treatment of patients with type 2 diabetes and mild hyperglycaemia

    Scherbaum, W. A., Schweizer, A., Mari, A., Peter Nilsson, Lalanne, G., Wang, Y., Dunning, B. E. & Foley, J. E., 2008, I : Diabetes, Obesity and Metabolism. 10, 11, s. 1114-1124

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Retinopathy in subjects with impaired fasting glucose The NANSY – Eye Study, Baseline report

    Tyrberg, M., Melander, A., Monica Lövestam Adrian & Lindblad, U., 2008, I : Diabetes, Obesity and Metabolism. 10, 8, s. 646-651

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. 2007
  55. Prediction of fat-free body mass from bioelectrical impedance among 9-to 11-year-old Swedish children

    Nielsen, B. M., Magnus Dencker, Ward, L., Christian Lindén, Ola Thorsson, Magnus Karlsson & Heitmann, B. L., 2007, I : Diabetes, Obesity and Metabolism. 9, 4, s. 521-539

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial

    Lund, S. S., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C. G., Frandsen, M., Smidt, U. M., Pedersen, O., Parving, H. -H. & Allan Vaag, 2007, I : Diabetes, Obesity and Metabolism. 9, 3, s. 394-407

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  57. 2006
  58. Residual risk for acute stroke in patients with type 2 diabetes and hypertension in primary care: Skaraborg Hypertension and Diabetes Project.

    Jungå, K., Juan Merlo, Bo Gullberg, Bog-Hansen, E., Lennart Råstam & Lindblad, U., 2006, I : Diabetes, Obesity and Metabolism. 8, 5, s. 492-500

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. 2005
Föregående 1 2 Nästa